Antlia Bioscience, Inc.
PrivateLast Round
Seed Round
Jun 5, 2026
Total Funding Raised
$1.21M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Antlia Bioscience, Inc. is a biopharmaceutical company that develops peptide-based therapies for the treatment of cardiovascular and metabolic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Antlia Bioscience, Inc. Comparables
Compare Antlia Bioscience, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| XL-protein | 76% | |
| Sanofi | 75% | |
| Vasa Therapeutics | 74% |
Antlia Bioscience, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Jun 5, 2026 | ||||
| VC Round | Apr 25, 2022 | ||||
| Seed | Oct 23, 2020 |
Antlia Bioscience, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| U.S. Department of Health and Human Services | Grant |
| National Heart, Lung, and Blood Institute | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 12, 2026
Monthly visitors increased 47% MoM.
- Jun 5, 2026
Raised $6M in a Seed Round.
Antlia Bioscience, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Antlia Bioscience, Inc.'s valuation, stock price, and market status.
Is Antlia Bioscience, Inc. a public or private company?
Antlia Bioscience, Inc. is a private company.
What is the current stock price of Antlia Bioscience, Inc.?
Antlia Bioscience, Inc. is a private company, so its shares have no public market price. Caplight tracks Antlia Bioscience, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Antlia Bioscience, Inc. worth (valuation)?
Valuation information for Antlia Bioscience, Inc. is not publicly available.
Can I buy Antlia Bioscience, Inc. stock?
Antlia Bioscience, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Antlia Bioscience, Inc.'s last funding round?
Antlia Bioscience, Inc.'s most recent funding round was Seed Round on June 5, 2026.
Who are the main investors in Antlia Bioscience, Inc.?
Key investors in Antlia Bioscience, Inc. include U.S. Department of Health and Human Services, National Heart, Lung, and Blood Institute.
Will Antlia Bioscience, Inc. IPO soon?
No public IPO plans have been announced for Antlia Bioscience, Inc..
How can I track Antlia Bioscience, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Antlia Bioscience, Inc.'s shares on secondary markets.